Bordetella pertussis: The intersection of genomics and pathobiology

CMAJ. Canadian Medical Association Journal

Volumn 173, Issue 1, 2005, Pages 55-62

  Preston, Andrew ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL TISSUE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIUM ISOLATE; BORDETELLA BRONCHISEPTICA; BORDETELLA PARAPERTUSSIS; BORDETELLA PERTUSSIS; CLINICAL FEATURE; GENOMICS; HUMAN; INCIDENCE; NONHUMAN; PATHOGENESIS; PERTUSSIS; REVIEW; SYMPTOMATOLOGY;

EID: 22144433344     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.050105     Document Type: Review

References (51)

1. Cherry JD. Historical review of pertussis and the classical vaccine. J Infect Dis 1996;174(S3):S259-63.
2. Vaccine preventable diseases: pertussis. Immunization and Respiratory Infections Division, Public Health Agency of Canada. Available: www.phac-aspc.gc.ca/dird-dimr/vpd-mev/pertussis_e.html (accessed 10 Jun 2005).
3. von Konig CH, Halperin S, Riffelmann M, Guiso N. Pertussis of adults and infants. Lancet Infect Dis 2002;2:744-50.
4. Senzilet LD, Halperin SA, Spika JS, Alagaratnam M, Morris A, Smith B; Sentinel Health Unit Surveillance System Pertussis Working Group. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis 2001;32:1691-7.
5. Nennig ME, Shinefield HR, Edwards KM, Black SB, Fireman BH. Prevalence and incidence of adult pertussis in an urban population. JAMA 1996;275:1672-4.
6. Cherry JD. Pertussis - the trials and tribulations of old and new pertussis vaccines. Vaccine 1992;10:1033-8.
7. Cherry JD. Acellular pertussis vaccines - a solution to the pertussis problem. J Infect Dis 1993;168:21-4.
8. Heininger U, Stehr K, Schmitt-Grohe S, Lorenz C, Rost R, Christenson PD, et al. Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatr Infect Dis J 1994;13:306-9.
9. Porter JF, Connor K, Donachie W. Isolation and characterization of Bordetella parapertussis-like bacteria from ovine lungs. Microbiology 1994;140:255-61.
10. Porter JF, Connor K, Donachie W. Differentiation between human and ovine isolates of Bordetella parapertussis using pulsed-field gel-electrophoresis. FEMS Microbiol Lett 1996;135:131-5.
11. Porter JF, Connor K, van der Zee A, Reubsaet F, Ibsen P, Heron I, et al. Characterization of ovine Bordetella parapertussis isolates by analysis of specific endotoxin (Lipopolysaccharide) epitopes, filamentous hemagglutinin production, cellular fatty-acid composition and antibiotic-sensitivity. FEMS Microbiol Lett 1995;132:195-201.
12. Van der Zee A, Mooi F, Van Embden J, Musser J. Molecular evolution and host adaptation of Bordetella spp.: phylogenetic analysis using multilocus enzyme electrophoresis and typing with three insertion sequences. J Bacteriol 1997;179:6609-17.
13. Goodnow RA. Biology of Bordetella bronchiseptica. Microbiol Rev 1980;44:722-38.
14. Keil DJ, Fenwick B. Role of Bordetella bronchiseptica in infectious tracheobronchitis in dogs. J Am Vet Med Assoc 1998;212:200-7.
15. Rutter JM. Quantitative observations on Bordetella bronchiseptica infection in atrophic rhinitis of pigs. Vet Rec 1981;108:451-4.
16. Skeeles JK, Arp LH. Bordetellosis (turkey coryza). In: Calnek BW, Barnes HJ, Beard CW, McDougald LR, Saif YM, editors. Diseases of poultry. 10th ed. Ames, IA: Iowa State University Press: 1997. p. 275-88.
17. Vandamme P, Heyndrickx M, Vancanneyt M, Hoste B, De Vos P, Falsen E, et al. Bordetella trematum sp nov., isolated from wounds and ear infections in humans, and reassessment of Alcaligenes denitrificans Ruger and Tan 1983. Int J Syst Bacteriol 1996;46:849-58.
18. Tang YW, Hopkins MK, Kolbert CP, Hartley PA, Severance PJ, Persing DH. Bordetella holmesii-like organisms associated with septicemia, endocarditis, and respiratory failure. Clin Infect Dis 1998;26:389-92.
19. Weyant RS, Hollis DG, Weaver RE, Amin MF, Steigerwalt AG, O'Connor SP, et al. Bordetella holmesii sp. nov., a new gram-negative species associated with septicemia. J Clin Microbiol 1995;33:1-7.
20. Cookson BT, Vandamme P, Carlson LC, Larson AM, Sheffield JV, Kersters K, et al. Bacteremia caused by a novel Bordetella species, "B. hinzii." J Clin Microbiol 1994;32:2569-71.
21. Funke G, Hess T, von Graevenitz A, Vandamme P. Characteristics of Bordetella hinzii strains isolated from a cystic fibrosis patient over a 3-year period. J Clin Microbiol 1996;34:966-9.
22. Vandamme P, Hommez J, Vancanneyt M, Monsieurs M, Hoste B, Cookson B, et al. Bordetella hinzii Sp-Nov, isolated from poultry and humans. Int J Syst Bacteriol 1995;45:37-45.
23. von Wintzingerode F, Schattke A, Siddiqui RA, Rosick U, Gobel UB, Gross R. Bordetella petrii sp. nov., isolated from an anaerobic bioreactor, and emended description of the genus Bordetella. Int J Syst Evol Microbiol 2001;51:1257-65.
24. Cotter PA, Miller JF, editors. Bordetella. In: Groisman EA. Principles of bacterial pathogenesis. San Diego, CA: Academic Press; 2001. p.619-74.
25. Anderton TL, Maskell DJ, Preston A. Ciliostasis is a key early event during colonization of canine tracheal tissue by Bordetella bronchiseptica. Microbiology 2004;150:2843-55.
26. Cummings CA, Brinig MM, Lepp PW, van de Pas S, Relman DA. Bordetella species are distinguished by patterns of substantial gene loss and host adaptation. J Bacteriol 2004;186:1484-92.
27. Parkhill J, Sebaihia M, Preston A, Murphy LD, Thomson N, Harris DE, et al. Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet 2003;35:32-40.
28. Preston A, Parkhill J, Maskell DJ. The Bordetellae: lessons from genomics. Nat Rev Microbiol 2004;2:379-90.
29. Arico B, Rappuoli R. Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes. J Bacteriol 1987;169:2847-53.
30. Pittman M. The concept of pertussis as a toxin-mediated disease. Pediatr Infect Dis 1984;3:467-86.
31. Wirsing von Konig, CH, Finger H. Role of pertussis toxin in causing symptoms of Bordetella parapertussis infection. Eur J Clin Microbiol Infect Dis 1994;13:455-8.
32. McGuirk P, Johnson PA, Ryan EJ, Mills KH. Filamentous hemagglutinin and pertussis toxin from Bordetella pertussis modulate immune responses to unrelated antigens. J Infect Dis 2000;182:1286-9.
33. McGuirk P, McCann C, Mills KH. Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis. J Exp Med 2002;195:221-31.
34. McGuirk P, Mills KH. Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases. Trends Immunol 2002;23:450-5.
35. Schouls LM, van der Heide HG, Vauterin L, Vauterin P, Mooi FR. Multiple-locus variable-number tandem repeat analysis of Dutch Bordetella pertussis strains reveals rapid genetic changes with clonal expansion during the late 1990s. J Bacteriol 2004;186:5496-505.
36. Van Loo IH, Mooi FR. Changes in the Dutch Bordetella pertussis population in the first 20 years after the introduction of whole-cell vaccines. Microbiology 2002;148:2011-8.
37. Mooi FR, van Loo IH, King AJ. Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence? Emerg Infect Dis 2001;7(3 Suppl):526-8.
38. Mooi FR, van Oirschot H, Heuvelman K, van der Heide HG, Gaastra W, Willems RJ. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in the Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect Immun 1998;66:670-5.
39. Boursaux-Eude C, Thiberge S, Carletti G, Guiso N. Intranasal murine model of Bordetella pertussis infection: II. Sequence variation and protection induced by a tricomponent acellular vaccine. Vaccine 1999;17:2651-60.
40. Hausman SZ, Burns DL. Use of pertussis toxin encoded by ptx genes from Bordetella bronchiseptica to model the effects of antigenic drift of pertussis toxin on antibody neutralization. Infect Immun 2000;68:3763-7.
41. Watanabe M, Nagai M. Whooping cough due to Bordetella parapertussis: an unresolved problem. Expert Rev Anti Infect Ther 2004;2:447-54.
42. Hewlett EL, Edwards KM. Clinical practice. Pertussis - not just for kids. N Engl J Med 2005;352:1215-22.
43. Farrell DJ, McKeon M, Daggard G, Loeffelholz MJ, Thompson CJ, Mukkur TK. Rapid-cycle PCR method to detect Bordetella pertussis that fulfills all consensus recommendations for use of PCR in diagnosis of pertussis. J Clin Microbiol 2000;38:4499-502.
44. Cloud JL, Hymas WC, Turlak A, Croft A, Reischl U, Daly JA, et al. Description of a multiplex Bordetella pertussis and Bordetella parapertussis LightCycler PCR assay with inhibition control. Diagn Microbiol Infect Dis 2003;46:189-95.
45. National Advisory Committee on Immunization. Prevention of pertussis in adolescents and adults. Can Commun Dis Rep 2003;29(ACS-5).
46. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 2005;18:326-82.
47. Forsyth KD, Campins-Marti M, Caro J, Cherry JD, Greenberg D, Guiso N, et al. New pertussis vaccination strategies beyond infancy: recommendations by the global pertussis initiative. Clin Infect Dis 2004;39:1802-9.
48. Serruto D, Adu-Bobie J, Capecchi B, Rappuoli R, Pizza M, Masignani V. Biotechnology and vaccines: application of functional genomics to Neisseria meningitidis and other bacterial pathogens. J Biotechnol 2004;113:15-32.
49. Capecchi B, Serruto D, Adu-Bobie J, Rappuoli R, Pizza M. The genome revolution in vaccine research. Curr Issues Mol Biol 2004;6:17-27.
50. Adu-Bobie J, Capecchi B, Serruto D, Rappuoli R, Pizza M. Two years into reverse vaccinology. Vaccine 2003;21:605-10.
51. Pizza M, Scarlato V, Masignani V, Giuliani MM, Arico B, Comanducci M, et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 2000;287:1816-20.